Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abexinostat in Lymphoma
NCT00724984Phase 2Completed
- Sponsor
- Pharmacyclics
- Start
- Jul 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abexinostat in Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL), sponsored by Pharmacyclics. Started Jul 2008; status: completed.
02
Drugs
abexinostat
03
Conditions
Hodgkin lymphoma (HL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00724984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00724984.